drugset
drugset / Trial / NCT00692718

N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure

NCT00692718 ↗

Phase 4 Unknown 160 enrolled Osaka General Medical Center
RandomizedParallel-groupOpen-labelPrevention

Summary

Our study is to investigate the effect of N-3 Fatty Acids for the prevention of atrial fibrillation in patients with acute heart failure or acute myocardial infarction

Timeline

Start
2008-07
Primary completion
2010-06
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Eicosapentaenoic acid Small molecule 900 mg —

Indications

acute myocardial infarction heart failure